The Development and Safety of Port Delivery System in Retinal Diseases

Expert insight on the history of the port delivery system in neovascular AMD and how it has impacted patient experience and outcomes.

Phase 2b study results of AR-15512 for the treatment of dry eye

At AAO 2021, Aerie Pharmaceuticals presented the results of their phase 2b clinical trial of AR-15512, a TRPM8 antagonist, for the treatment of dry eye.

Managing senior-specific complications of diabetic eye disease

Confronting issues unique to aging may lead to better outcomes.